Key Quantitative Figures - Standalone (FY Ended 31/03/2026)

  • Revenue from Operations: ₹1,739.18 lakhs (FY 2025: ₹521.97 lakhs)
  • Total Income: ₹2,088.52 lakhs (FY 2025: ₹867.67 lakhs)
  • Total Expenses: ₹3,139.11 lakhs (FY 2025: ₹771.59 lakhs)
  • Loss Before Tax: ₹1,050.58 lakhs (FY 2025: Profit of ₹96.08 lakhs)
  • Net Loss: ₹1,042.29 lakhs (FY 2025: Profit of ₹66.32 lakhs)
  • Basic EPS: (₹0.16) (FY 2025: ₹0.01)
  • Diluted EPS: (₹0.15) (FY 2025: ₹0.00)
  • Paid-up Equity Share Capital: ₹6,545.15 lakhs (Face Value Re.1/-)

Key Quantitative Figures - Consolidated (FY Ended 31/03/2026)

  • Revenue from Operations: ₹30,857.56 lakhs (FY 2025: ₹11,069.87 lakhs)
  • Total Income: ₹32,088.93 lakhs (FY 2025: ₹11,219.07 lakhs)
  • Profit Before Tax: ₹4,658.38 lakhs (FY 2025: ₹270.92 lakhs)
  • Net Profit: ₹3,101.94 lakhs (FY 2025: ₹120.79 lakhs)
  • Basic EPS: ₹0.48 (FY 2025: ₹0.02)
  • Diluted EPS: ₹0.45 (FY 2025: ₹0.02)
  • Paid-up Equity Share Capital: ₹6,545.15 lakhs

Dividend Declaration

The Board has recommended a final dividend of ₹0.05 per equity share (face value of ₹1 each) for the financial year ended March 31, 2026. The dividend shall be paid/dispatched within 30 days from the date of the ensuing Annual General Meeting, upon approval by the members.

The date of the ensuing Annual General Meeting will be intimated to the Stock Exchanges in due course.

Appointment of Internal Auditors

On the recommendation of the Audit Committee, the Board approved the appointment of S. Ramanand Aiyer & Co., Chartered Accountants (FRN: 000990N), as Internal Auditors for the Financial Year 2026-27. This is a re-appointment.

Regulatory References and Auditor Confirmation

The Statutory Auditors, M/s. Bilimoria Mehta & Co., Chartered Accountants, Mumbai (FRN: 101490W), have issued their audit report on both Standalone and Consolidated Financial Statements with an unmodified opinion.

A declaration under Regulation 33(3)(d) of the SEBI LODR Regulations, 2015, confirming the unmodified audit opinion, was signed by Mr. Ravindran Govindan, Chairman & Managing Director.

Capital Structure Impact

Effective from the record date of September 12, 2025, the company sub-divided its equity shares from ₹10 each into 10 equity shares of ₹1 each. The paid-up share capital post-subdivision is ₹6,545.15 lakhs. All per-share data (EPS) for current and comparative periods has been proportionately adjusted for consistency.

Subsidiary and Associate Updates

  • During Q1 FY26, the company incorporated FMV Global Innovation Pte Ltd, which is included in the consolidation.
  • During Q4 FY26, the entire investment in Pellucidcare Health Innovations Pte Ltd (formerly FMV HealthCare PTE Ltd.) was transferred to its wholly-owned subsidiary, Flynncare HealthCare Innovations Private Limited. This made Pellucidcare a step-down subsidiary, with no change in ultimate ownership.
  • The consolidated results include numerous subsidiaries and associates, detailed in Annexure 1 of the auditors' report.

Other Significant Notes

  • The implementation of the New Labour Codes (effective November 21, 2025) was assessed. Management concluded no material incremental impact on gratuity obligations and does not expect a material impact on other areas. The company continues to monitor for any future impact.
  • The Board Meeting commenced at 9:00 PM IST and concluded at 11:00 PM IST on May 29, 2026.